A cell-permeable peptide mimicking the kinase-inhibitory region of SOCS1 regulatory protein could halt the onset and progression of renal inflammation and fibrosis in DN by inhibiting STAT1 and STAT3 [139]. Here, STAT1 is linked to liver dysplastic nodule.